Barnwell Industries, Inc. revenue by segment BRN

Barnwell Industries, Inc. splits its revenue into 4 lines in its filings. The largest line in fiscal 2025, which ended Sep 30, 2025 was Oil And Natural Gas at $13.6 million, 99% of the total.

USD in millions. The percent under a figure is the change from the year before.

Line
FY 2026
Jun 30, 2026
FY 2025
Sep 30, 2025
FY 2024
Sep 30, 2024
FY 2023
Sep 30, 2023
FY 2022
Sep 30, 2022
FY 2021
Sep 30, 2021
FY 2020
Sep 30, 2020
FY 2019
Sep 30, 2019
FY 2018
Sep 30, 2018
FY 2017
Sep 30, 2017
FY 2016
Sep 30, 2016
Revenue
12
14
18
25
29
18
18
12
9
13
14
Oil And Natural Gas
11
-19.9%
share 98.6%
14
-22.0%
share 99.4%
17
-10.2%
share 96.7%
19
-14.2%
share 76.9%
23
+120.2%
share 79.2%
10
+53.2%
share 56.6%
7
share 36.5%
—
—
—
—
Contract Drilling
—
—
4
-33.4%
share 20.1%
5
+19.5%
share 21.6%
5
-21.8%
share 15.9%
6
-47.2%
share 32.1%
11
share 60.0%
—
—
—
—
Land Investment
—
—
0
+88.7%
share 2.8%
0
-79.5%
share 1.1%
1
-25.5%
share 4.5%
2
+434.8%
share 9.6%
0
share 1.8%
—
—
—
—
All Other Segments
0
+4.3%
share 1.4%
0
-25.1%
share 1.0%
0
-10.9%
share 1.0%
0
+55.8%
share 0.8%
0
-58.7%
share 0.5%
0
-6.9%
share 1.7%
0
share 1.8%
—
—
—
—
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry
Crude Petroleum & Natural Gas (SIC 1311)
Listed as
BRN (NYSE)
Fiscal year ends
September 30
Incorporated in
DE
Headquarters
Houston, TX
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
10048

Other Crude Petroleum & Natural Gas companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.